Baxter to Host First Quarter 2018 Financial Results Conference Call for Investors
Published: Apr 04, 2018
To access the call, dial 844-886-1929 (domestic) or 225-239-4663 (international). Please dial into the call at least 10 minutes prior to the start for the operator to connect you. The Conference ID is 9881128.
This call is also being webcast by Nasdaq OMX and can be accessed at Baxter’s website at www.baxter.com. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter’s permission.
Baxter International Inc. provides a broad portfolio of essential healthcare products across its portfolio, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.